J. Padia

发表

Discovery and Preclinical Development of Antigiardiasis Fumagillol Derivatives

O. Herzberg, L. Kulakova, A. Galkin, 2020, Antimicrobial Agents and Chemotherapy.

Design and synthesis of novel nonpeptide CCK-B receptor antagonists

B. K. Trivedi, R. Pinnock, J. Padia, 1997 .

Growth inhibition of imatinib-resistant CML cells with the T315I mutation and hypoxia-adaptation by AV65--a novel Wnt/β-catenin signaling inhibitor.

J. Strovel, Y. Hayashi, H. Hirai, 2011, Cancer letters.

Design, Synthesis, and Biological Evaluation of a Series of Anthracene-9,10-dione Dioxime β-Catenin Pathway Inhibitors.

K. Bhalla, R. Soldi, Sunil Sharma, 2015, Journal of medicinal chemistry.

Second generation "peptoid" CCK-B receptor antagonists: identification and development of N-(adamantyloxycarbonyl)-alpha-methyl-(R)-tryptophan derivative (CI-1015) with an improved pharmacokinetic profile.

S. Rose, M. J. Field, B. K. Trivedi, 1998, Journal of medicinal chemistry.

Inhibitors of lipoprotein(a) assembly.

Jason K. Pontrello, B. Roth, P. Liao, 2003, Bioorganic & medicinal chemistry.

7β-hydroxy bile alcohols: Facile synthesis and 2D 1H NMR studies of 5β-cholestane-3α,7β,12α,25-tetrol

N. Ertel, G. Salen, J. Padia, 1997, Steroids.

Novel nonpeptide CCK-B antagonists: design and development of quinazolinone derivatives as potent, selective, and orally active CCK-B antagonists.

B. Roth, K. Meecham, M. Field, 1998, Journal of medicinal chemistry.

Lithium hydroxide/aqueous methanol: mild reagent for the hydrolysis of bile acid methyl esters

G. Tint, S. Shefer, G. Salen, 1990, Steroids.

Dichloro[1,2‐bis(diphenylphosphino)ethane]palladium(II)

T. Colacot, J. Padia, C. Barnard, 2009 .

Efficient, large-scale synthesis and preclinical studies of MRS5698, a highly selective A3 adenosine receptor agonist that protects against chronic neuropathic pain

K. Jacobson, D. Salvemini, D. Tosh, 2015, Purinergic Signalling.

Bioisosterism in drug design: identification of and structure-activity relationships in a series of glycine anilide ACAT inhibitors.

C. J. Blankley, R. Stanfield, B. Roth, 1995, Bioorganic & medicinal chemistry.

Bile alcohol glucuronides: regioselective O-glucuronidation of 5β-cholestane-3α,7α,12α,25-tetrol and 24-nor-5β-cholestane-3α,7α,12α,25-tetrol

G. Tint, S. Shefer, G. Salen, 1993 .

Stereoselective synthesis of (24R and 24S) 5β-cholestane-3α,7α,12α,24,25-pentols and (25R and 25S) 5β-cholestane 3α,7α,12α,25,26-pentols using a modified osmium-catalyzed Sharpless asymmetric dihydroxylation process

G. Tint, S. Shefer, G. Salen, 1992 .

Efficient, large-scale synthesis and preclinical studies of MRS5698, a highly selective A3 adenosine receptor agonist that protects against chronic neuropathic pain

K. Jacobson, D. Salvemini, D. Tosh, 2015, Purinergic Signalling.

Three classes of glucocerebrosidase inhibitors identified by quantitative high-throughput screening are chaperone leads for Gaucher disease

Christopher P Austin, Anton Simeonov, Wei Zheng, 2007, Proceedings of the National Academy of Sciences.

AV-65, a novel Wnt/β-catenin signal inhibitor, successfully suppresses progression of multiple myeloma in a mouse model

J. Strovel, M. Taniwaki, Y. Hayashi, 2011, Blood cancer journal.

Inhibition of Wnt/β-Catenin Signaling by AV65 Treatment Caused Cell Cycle Arrest and Induced Caspase-Independent or -Dependent Apoptosis in CML Cells.

J. Strovel, H. Hirai, S. Kimura, 2009 .